 NOVOGEN LIMITED Company Summary
|
| Pharmaceutical research and development and manufacturing and marketing of health supplements. |
|
| Company Data |
 |
Fax |
(02) 9878 0055 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
1994/09/01 |
|
|
Homepage |
www.novogen.com |
|
| |
| Markets | | Stock Exchange | Stock Code | | ASX | NRT | | | NASDAQ | NVGN | | | |
|
|
| MultiMedia |
|
|
|  Novogen Limited ASX: NRT - 2007 Annual General Meeting - Mr Christopher Naughton, MD (OCT 27, 2007) | | Novogen Limited ASX: NRT - August 2007 Investor Presentation - Mr Christopher Naughton, MD (AUG 30, 2007) | | Novogen Limited ASX: NRT - Subsidiary Raises US$16.4 M And Promising Results For Anti-Inflammatory Drug - Mr Christopher Naughton, MD (AUG 7, 2007) | | Novogen Limited ASX: NRT - Ovarian Tumour Response Trial Recruits First US Patients - Mr Christopher Naughton, MD (JUNE 5, 2007) | | Novogen Limited ASX: NRT - Company Update - Mr Christopher Naughton, MD (MAY 14, 2007) | | Novogen Limited ASX: NRT - Company Update - Mr Christopher Naughton, MD (MAR 6, 2007) | | Novogen Limited Subsidiary Marshall Edwards Inc 2006 AGM - Speaker Three: Dr Harriet Kluger, Assistant Professor, Yale Cancer Center (DEC 15, 2006) | | Novogen Limited Subsidiary Marshall Edwards Inc 2006 AGM - Speaker Two: Prof. Alan Husband, Executive Director (DEC 15, 2006) | | Novogen Limited Marshall Edwards Inc 2006 AGM - Mr Chris Naughton, CEO (DEC 15, 2006) | | Novogen Limited ASX: NRT - Annual General Meeting (NOV 2, 2006) | | NOVOGEN LIMITED ASX: NRT - Market Update - Mr Chris Naughton, CEO (MAY 23, 2006) |
|
